Pharmacokinetics of the tablet formulation of lopinavir/r [lopinavir/ritonavir] as standard and increased dosage during pregnancy in HIV-infected women.
Phase of Trial: Phase IV
Latest Information Update: 10 Mar 2014
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications HIV infections
- Focus Pharmacokinetics
- 23 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Mar 2012 Planned end date changed from 1 Feb 2010 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 24 Jun 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.